Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mallarkey, Gordon
56  Ergebnisse:
Personensuche X
?
1

What we are doing to help researchers publish their papers ..:

Mallarkey, Gordon ; Thorne, Matthew
Journal of International Medical Research.  50 (2022)  5 - p. 030006052211009 , 2022
Link: https://doi.org/10.1177/..
 
?
2

What we are doing to help researchers publish their papers ..:

Mallarkey, Gordon ; Thorne, Matthew
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130814/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

What we are doing to help researchers publish their papers ..:

Gordon Mallarkey ; Matthew Thorne
https://doi.org/10.1177/03000605221100927.  , 2022
Link: https://doi.org/10.1177/..
 
?
4

Therapeutic management of hyperlipoproteinemia (a):

Constantine E Kosmas ; Andreas Sourlas ; Gordon Mallarkey...
https://www.drugsincontext.com/therapeutic-management-of-hyperlipoproteinemia-(a)/.  , 2019
Link: https://doi.org/10.7573/..
 
?
5

Therapeutic management of hyperlipoproteinemia (a):

Kosmas, Constantine E ; Sourlas, Andreas ; Mallarkey, Gordon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752750/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
6

Cardiac myosin activators for heart failure therapy: focus ..:

Edgardo Kaplinsky ; Gordon Mallarkey
http://www.drugsincontext.com/cardiac-myosin-activators-for-heart-failure-therapy-focus-on-omecamtiv-mecarbil.  , 2018
Link: https://doi.org/10.7573/..
 
?
7

European Society for Medical Oncology Copenhagen update: po..:

Gordon Mallarkey ; Axel Grothey
https://doi.org/10.1177/1758834016679105.  , 2017
Link: https://doi.org/10.1177/..
 
?
8

Osteoporosis therapeutics: recent developments at ASBMR:

Mallarkey, Gordon ; Reid, David M.
Therapeutic Advances in Musculoskeletal Disease.  8 (2016)  1 - p. 3-7 , 2016
Link: https://doi.org/10.1177/..
 
?
9

Latest therapeutic advances in musculoskeletal disease from..:

Reid, David M. ; Mallarkey, Gordon
Therapeutic Advances in Musculoskeletal Disease.  8 (2016)  1 - p. 8-14 , 2016
Link: https://doi.org/10.1177/..
 
?
10

European Society for Medical Oncology Copenhagen update: po..:

Mallarkey, Gordon ; Grothey, Axel
Therapeutic Advances in Medical Oncology.  9 (2016)  1 - p. 4-12 , 2016
Link: https://doi.org/10.1177/..
 
?
11

European Society for Medical Oncology Copenhagen update: po..:

Mallarkey, Gordon ; Grothey, Axel
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298453/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
12

Osteoporosis therapeutics: recent developments at ASBMR:

Mallarkey, Gordon ; Reid, David M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707418/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
13

Latest therapeutic advances in musculoskeletal disease from..:

Reid, David M ; Mallarkey, Gordon
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707419/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
14

Targeting precision medicine toxicity: recent developments:

Mallarkey, Gordon ; Mangoni, Arduino A.
Therapeutic Advances in Drug Safety.  6 (2015)  1 - p. 4-14 , 2015
Link: https://doi.org/10.1177/..
 
?
15

Targeting precision medicine toxicity: recent developments:

Mallarkey, Gordon ; Mangoni, Arduino A
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2015
Link: http://www.ncbi.nlm.nih...
 
1-15